News on Medial

Lexeo Therapeutics Raises $80 Million Led by Frazier and Janus to Advance Cardiovascular Genetic Medicines with AAVrh10 Vector | DeepNewz VC

Business Bytes · 2m ago

Medial

Lexeo Therapeutics has successfully raised $80 million in a funding round led by Frazier and Janus, aimed at advancing its cardiovascular treatments. At the same time, GlycoEra has secured $130 million in a Series B financing round to focus on developing extracellular degraders for treating autoimmune diseases. These significant investments underscore the growing interest and innovation in biotechnology, targeting critical health issues like cardiovascular conditions and autoimmunity.